Overview

Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The primary objective is to evaluate the safety profile and tolerability of rituximab in combination with different chemotherapy regimens.
Details
Lead Sponsor:
Hoffmann-La Roche
Treatments:
Rituximab